mg ml to 50 mg ml in at least one additional aspect of the present disclosure the concentration of drug molecule ranges from 0 5 mg ml to 10 mg ml and the percent of peg carbohydrate lipid ranges from 0 5 to 10 w v of the total solution further aspects of the present disclosure may provide aqueous injectable drug solutions in which the diluent consists of 0 5 to 25 percent w v of the peg carbohydrate lipid and 75 to 99 5 percent v v of water or a buffer or saline or dextrose solution also preferable are aqueous injectable drug solutions of this invention in which 85 to 99 percent v v of the total solution is water or a buffer or saline or dextrose solution in at least one aspect of the present disclosure aqueous injectable drug solutions according to the present invention comprise lipophilic drug compound in lcp lipids including and not limited to otl peg or odl peg plus aqueous media at concentrations of a drug ranging from 0 5 mg ml to 50 mg ml 0 5 to 25 percent w v of peg carbohydrate lipid and 75 to 99 5 percent v v water wherein the concentration of drug in the combined solution ranges from 0 5 to.